(Q56541717)

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Mechanistic review of drug-induced steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Toxicant-associated steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Mechanisms of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Predicting the mechanism of phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Drug induced phospholipidosis: an acquired lysosomal storage disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

The mechanistic basis for the induction of hepatic steatosis by xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

AMP-activated protein kinase control of fat metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

A simple transcriptomic signature able to predict drug-induced hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Animal models of NASH: getting both pathology and metabolic context right

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Pathogenesis of NASH: animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Uridine prevents tamoxifen-induced liver lipid droplet accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Tetracycline-induced steatosis in primary canine hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Cytometric analysis for drug-induced steatosis in HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Infection of a human hepatoma cell line by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Production of hepatocyte-like cells from human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Temporal gene expression analysis of monolayer cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Pancreas islets in metabolic signaling--focus on the beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Insulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Liver tissue engineering in the evaluation of drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Perfused multiwell plate for 3D liver tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Steatohepatitis secondary to long-term glucocorticoid treatment for congenital adrenal hyperplasia: a potential diagnostic pitfall

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2017.1246534

Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver

21 January 2018

1 reference

12 December 2020

Steatosis and liver stiffness measurements using transient elastography

1 reference

12 December 2020

Laminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing

1 reference

12 December 2020

Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions

1 reference

12 December 2020

Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery

1 reference

12 December 2020

NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis

1 reference

12 December 2020

Drug metabolism by the human hepatoma cell, Hep G2

1 reference

12 December 2020

CASH (Chemotherapy-Associated Steatohepatitis) costs

1 reference

12 December 2020

Fatty liver and drugs

1 reference

12 December 2020

Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis

1 reference

12 December 2020

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

12 December 2020

Lessons from animal models of NASH

1 reference

12 December 2020

Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

1 reference

12 December 2020

NASH animal models: are we there yet?

1 reference

12 December 2020